JPMorgan downgraded Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) from a Neutral rating to an Underweight rating sending the stock price tumbling $1.01 to close at $9.37.
Ariad Pharmaceuticals downgraded
October 24, 2016 at 17:46 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|